{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:40:21Z","timestamp":1791333621936,"version":"4.3.1"},"reference-count":24,"publisher":"Georg Thieme Verlag KG","issue":"05","license":[{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Background Congenital aniridia is a severe malformation of almost all eye segments. Aniridia-associated keratopathy (AAK) and secondary glaucoma, which occur in more than 50% of affected individuals, are typically progressive and pose a high risk of blindness for patients with congenital aniridia. Our aim was to investigate the effect of glaucoma treatment on AAK in patients of the Homburg Aniridia Center.<\/jats:p><jats:p>\n          Methods Our retrospective monocentric study included patients who underwent a comprehensive ophthalmological examination at the Homburg Aniridia Center between June 2003 and January 2022.<\/jats:p><jats:p>\n          Results There were 556 eyes of 286 subjects (20.1\u2009\u00b1\u200920.1 years; 45.5% males) included. In 307 (55.2%) eyes of 163 subjects (27.5\u2009\u00b1\u200916.3 years; 43.1% males), glaucoma was present at the time of examination. The mean intraocular pressure in the glaucoma group was 19.0\u2009mmHg (\u00b1\u20098.0), while in the non-glaucoma group, it was 14.1\u2009mmHg (\u00b1\u20093.6) (p\u2009&lt;\u20090.001). In the glaucoma group, 68 patients used antiglaucomatous topical monotherapy, 51 patients used 2 agents, 41 patients used 3\u00a0agents, 7 patients used quadruple therapy, and 140 did not use topical therapy (e.g., after pressure-lowering surgery, pain-free end-stage glaucoma, or incompliance). Patients were classified according to the following stages of AAK: Stage 0 (96 eyes [17.2%], no keratopathy), Stage 1 (178 eyes [32.0%]), Stage 2 (107 eyes [19.2%]), Stage 3 (67 eyes [12.0%]), Stage 4 (62 eyes [11.1%]), Stage 5 (45 eyes [8.0%]). The mean stage of AAK was 1.4 (1.2\u200a\u2013\u200a1.5) in the group without eye drops, 1.9 (1.5\u200a\u2013\u200a2.2)\n          in the group with monotherapy, 1.8 (1.5\u200a\u2013\u200a2.1) in the group with 2 drugs, 1.9\u00a0(1.5\u200a\u2013\u200a2.2) in the group with 3 drugs, 3.4 (2.3\u200a\u2013\u200a4.6) in the group with 4 drugs, and 3.3 (3.1\u200a\u2013\u200a3.6) after antiglaucomatous surgery. The stage of AAK was significantly positively correlated with the number of pressure-lowering eye drops (p\u2009&lt;\u20090.05) and prior pressure-lowering surgery (p\u2009&lt;\u20090.05). Prostaglandin analogues were not correlated with a higher AAK stage compared to the other drug groups.<\/jats:p><jats:p>\n          Conclusions At the Homburg Aniridia Center, patients using topical antiglaucomatous quadruple therapy or who had previously undergone antiglaucomatous surgery had by far the highest AAK stage. The different drug groups had no influence on the AAK stage.<\/jats:p>","DOI":"10.1055\/a-2194-1580","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T22:59:51Z","timestamp":1697669991000},"page":"578-583","source":"Crossref","is-referenced-by-count":11,"title":["The Effect of Glaucoma Treatment on Aniridia-Associated Keratopathy (AAK) \u2013 A Report from the Homburg Register for Congenital Aniridia"],"prefix":"10.1055","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8526-4712","authenticated-orcid":false,"given":"Fabian Norbert","family":"Fries","sequence":"additional","affiliation":[{"name":"Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland University, Homburg\/Saar, Germany"},{"name":"Department of Ophthalmology, Saarland University Medical Center, Homburg\/Saar, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annam\u00e1ria","family":"N\u00e1ray","sequence":"additional","affiliation":[{"name":"Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland University, Homburg\/Saar, Germany"},{"name":"Department of Ophthalmology, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Munteanu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Saarland University Medical Center, Homburg\/Saar, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Stachon","sequence":"additional","affiliation":[{"name":"Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland University, Homburg\/Saar, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Lagali","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Faculty of Medicine, Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9701-8204","authenticated-orcid":false,"given":"Berthold","family":"Seitz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Saarland University Medical Center, Homburg\/Saar, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5137-8658","authenticated-orcid":false,"given":"Barbara","family":"K\u00e4smann-Kellner","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Saarland University Medical Center, Homburg\/Saar, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00f3ra","family":"Szentm\u00e1ry","sequence":"additional","affiliation":[{"name":"Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland University, Homburg\/Saar, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,12,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/a-2065-8405","article-title":"A Cross-sectional Analysis of 556\u00a0Eyes Entering the Homburg Aniridia Centre","volume":"240","author":"F N Fries","year":"2023","journal-title":"Klin Monbl Augenheilkd"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/ca.22987","article-title":"Diagnostic impact of anterior segment angiography of limbal stem cell insufficiency in PAX6-related aniridia","volume":"31","author":"B K\u00e4smann-Kellner","year":"2018","journal-title":"Clin Anat"},{"issue":"S 1","key":"ref3","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/j.oftale.2020.11.011","article-title":"Aniridic glaucoma: An\u00a0update","volume":"96","author":"F J Mu\u00f1oz-Negrete","year":"2021","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ca.22935","article-title":"Clinical anatomy of the anterior chamber angle in congenital aniridia and consequences for trabeculotomy\/cyclophotocoagulation","volume":"31","author":"A Viestenz","year":"2018","journal-title":"Clin Anat"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00347-014-3060-x","article-title":"[Aniridia syndrome: clinical findings, problematic courses and suggestions for optimization of care (\u201caniridia guide\u201d)]","volume":"111","author":"B K\u00e4smann-Kellner","year":"2014","journal-title":"Ophthalmologe"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s00347-014-3058-4","article-title":"[Congenital aniridia or PAX6 syndrome]","volume":"111","author":"B K\u00e4smann-Kellner","year":"2014","journal-title":"Ophthalmologe"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s00347-014-3061-9","article-title":"[Stage-related therapy of congenital aniridia]","volume":"111","author":"B Seitz","year":"2014","journal-title":"Ophthalmologe"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1007\/s10792-021-01982-z","article-title":"An attempt to optimize the outcome of penetrating keratoplasty in congenital aniridia-associated keratopathy (AAK)","volume":"41","author":"C J Farah","year":"2021","journal-title":"Int Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4274\/tjo.galenos.2019.07348","article-title":"Short- and Long-term Results of Glaucoma Valve Implantation for Aniridia-related Glaucoma: A Case Series and Literature Review","volume":"49","author":"G Soyugelen Demirok","year":"2019","journal-title":"Turk J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/archopht.124.4.471","article-title":"Effect of central corneal thickness, corneal curvature, and axial length on applanation tonometry","volume":"124","author":"M Kohlhaas","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.survophthal.2021.02.011","article-title":"Congenital aniridia \u2013 A comprehensive review of clinical features and therapeutic approaches","volume":"66","author":"E CS Landsend","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.survophthal.2023.04.003","article-title":"Future directions in managing aniridia-associated keratopathy","volume":"68","author":"A JH van Velthoven","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jtos.2023.05.010","article-title":"Report on the 2021 Aniridia North America symposium on PAX6, aniridia, and beyond","volume":"29","author":"R M Grainger","year":"2023","journal-title":"Ocul Surf"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s10038-022-01115-z","article-title":"A new association of PAX6 variation with Juvenile onset open angle glaucoma","volume":"68","author":"V Gupta","year":"2023","journal-title":"J Hum Genet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/s0181-5512(07)89576-3","article-title":"[Glaucoma in aniridia]","volume":"30","author":"D Bremond-Gignac","year":"2007","journal-title":"J Fr Ophtalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2021-320774","article-title":"Early ocular surface and tear film status in congenital aniridia indicates a supportive treatment window","author":"F N Fries","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"108904","DOI":"10.1016\/j.exer.2021.108904","article-title":"Decreased FABP5 and DSG1 protein expression following PAX6 knockdown of differentiated human limbal epithelial cells","volume":"215","author":"P Katiyar","year":"2022","journal-title":"Exp Eye Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ophtha.2019.09.034","article-title":"PAX6 Mutational Status Determines Aniridia-Associated Keratopathy Phenotype","volume":"127","author":"N Lagali","year":"2020","journal-title":"Ophthalmology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jtos.2019.11.002","article-title":"Early phenotypic features of aniridia-associated keratopathy and association with PAX6 coding mutations","volume":"18","author":"N Lagali","year":"2020","journal-title":"Ocul Surf"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jtos.2021.09.001","article-title":"Pathophysiology of aniridia-associated keratopathy: Developmental aspects and unanswered questions","volume":"22","author":"L Latta","year":"2021","journal-title":"Ocul Surf"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3390\/biom11111651","article-title":"Similarities in DSG1 and KRT3 Downregulation through Retinoic Acid Treatment and PAX6 Knockdown Related Expression Profiles: Does PAX6 Affect RA Signaling in Limbal Epithelial Cells?","volume":"11","author":"L Latta","year":"2021","journal-title":"Biomolecules"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jtos.2020.04.014","article-title":"Abnormal neovascular and proliferative conjunctival phenotype in limbal stem cell deficiency is associated with altered microRNA and gene expression modulated by PAX6 mutational status in congenital aniridia","volume":"19","author":"L Latta","year":"2021","journal-title":"Ocul Surf"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.exer.2018.10.002","article-title":"Expression of retinoic acid signaling components ADH7 and ALDH1A1 is reduced in aniridia limbal epithelial cells and a siRNA primary cell based aniridia model","volume":"179","author":"L Latta","year":"2019","journal-title":"Exp Eye Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jtos.2021.06.002","article-title":"Dysfunction of the limbal epithelial stem cell niche in aniridia-associated keratopathy","volume":"21","author":"U Schl\u00f6tzer-Schrehardt","year":"2021","journal-title":"Ocul Surf"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2194-1580.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T22:34:02Z","timestamp":1747866842000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2194-1580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,18]]},"references-count":24,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2025,5,21]]},"published-print":{"date-parts":[[2025,5]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2194-1580","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"value":"0023-2165","type":"print"},{"value":"1439-3999","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,18]]},"published":{"date-parts":[[2023,10,18]]}}}